tiprankstipranks
Johnson & Johnson Shs (TSE:JNJ)
TSX:JNJ
Canadian Market
Want to see TSE:JNJ full AI Analyst Report?

Johnson & Johnson Shs (JNJ) Stock News & Sentiment

5 Followers
Underappreciated Autoimmune Franchise Potential Keeps Johnson & Johnson at Buy with Unchanged $275 Price Target
Premium
Ratings
Underappreciated Autoimmune Franchise Potential Keeps Johnson & Johnson at Buy with Unchanged $275 Price Target
7d ago
Johnson & Johnson: Diversified Growth, Robust Pipeline, and Attractive Risk‑Reward Support Buy Rating
Premium
Ratings
Johnson & Johnson: Diversified Growth, Robust Pipeline, and Attractive Risk‑Reward Support Buy Rating
28d ago
Early Icotyde Approval Strengthens Johnson & Johnson’s Immunology Growth Outlook and Multi‑Billion‑Dollar Potential
Premium
Ratings
Early Icotyde Approval Strengthens Johnson & Johnson’s Immunology Growth Outlook and Multi‑Billion‑Dollar Potential
2M ago

News Score - Last 7 Days

Very Positive
TSE:JNJ
Sector Average
Media Buzz
This Week16 articles
Weekly Average7.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is TSE:JNJ’s Media Buzz Sentiment?
16 articles about TSE:JNJ were published this week. In an average week, 7.5 articles are published.
    What is TSE:JNJ’s weekly average amount of articles?
    In an average week, 7.5 articles about TSE:JNJ are published.
      What is TSE:JNJ’s News Sentiment?
      100% of articles about TSE:JNJ were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        Showing the stocks with the most bullish news sentiment over the past week